Abiraterone and Increased Survival in Metastatic Prostate Cancer
Abiraterone and Increased Survival in Metastatic Prostate Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Abiraterone and Increased Survival in Metastatic Prostate Cancer have?
Abiraterone and Increased Survival in Metastatic Prostate Cancer has 4,422 citations in the OpenAlex counts ScholarIQ stores.
When was Abiraterone and Increased Survival in Metastatic Prostate Cancer published?
Abiraterone and Increased Survival in Metastatic Prostate Cancer has 2011 year in the ScholarIQ index.
What is the open-access status of Abiraterone and Increased Survival in Metastatic Prostate Cancer?
Abiraterone and Increased Survival in Metastatic Prostate Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Abiraterone and Increased Survival in Metastatic Prostate Cancer?
The DOI for Abiraterone and Increased Survival in Metastatic Prostate Cancer is on the source record.
What is the PMID of Abiraterone and Increased Survival in Metastatic Prostate Cancer?
The PMID for Abiraterone and Increased Survival in Metastatic Prostate Cancer is on the source record.
What is the OpenAlex record for Abiraterone and Increased Survival in Metastatic Prostate Cancer?
The OpenAlex for Abiraterone and Increased Survival in Metastatic Prostate Cancer is on the source record.